Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Warning Letters
Manufacturing
Swedish contract manufacturer hit with FDA warning letter
Rechon Life Sciences received a warning letter from the FDA following a 2024 inspection that uncovered unsanitary conditions at its production plant.
Joseph Keenan
Jun 9, 2025 9:09am
AACE Pharma slammed with FDA warning letter for CMO’s shortfalls
May 29, 2025 10:11am
Aurobindo discloses FDA Form 483 at North Carolina inhaler plant
Apr 14, 2025 3:00pm
Aspen Pharmacare hit with warning letter citing sterility issues
Mar 20, 2025 9:45am
FDA hits 2 Indian API makers with warning letters, import alerts
Feb 20, 2025 9:05am
Viatris says India plant hit with FDA warning letter, import ban
Dec 23, 2024 10:50am